Pay in 4 interest-free payments of $6.56 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Hormone therapy in patients with invasive breast cancer or those with increased risk of recurrence
Most are manageable with dose adjustments or supportive care
When present, it is usually associated with dose increases and resolves quickly
This can lead to inaccurate dosing and compromised compound integrity
Levine, MD
Case Study 1: Managing Weight Loss and Thyroid Function Jane, a 46-year-old female with type 2 diabetes, obesity, and hypothyroidism, was started on semaglutide to improve glycemic control and aid in weight loss
US$ 23.02
US$ 23.64
US$ 26.88
US$ 23.22
US$ 25.84
US$ 25.75
